Living donor liver transplant for fibrolamellar hepatocellular carcinoma using a deceased donor graft to reconstruct inferior vena cava
- PMID: 15048801
- DOI: 10.1002/lt.20132
Living donor liver transplant for fibrolamellar hepatocellular carcinoma using a deceased donor graft to reconstruct inferior vena cava
Abstract
Liver transplantation is now an acceptable treatment for small hepatocellular carcinomas in the setting of cirrhosis. Larger tumors in cirrhotic livers and unresectable tumors in noncirrhotic livers (including fibrolamellar hepatocellular carcinomas) may also be indications for transplantation. With the limited number of cadaver grafts available, living donor liver transplant is becoming an option for some of these patients. We describe a method of reconstruction of the recipient inferior vena cava with deceased donor graft in right lobe living donation for fibrolamellar hepatocellular carcinoma.
Similar articles
-
Living-donor liver transplant with an interposition graft of the inferior vena cava for hepatocellular carcinoma: beyond the Milan criteria and within the UCSF criteria.Exp Clin Transplant. 2013 Jun;11(3):283-6. doi: 10.6002/ect.2012.0133. Epub 2012 Nov 19. Exp Clin Transplant. 2013. PMID: 23176663
-
Liver transplant for hepatocellular carcinoma: experience in a Saudi population.Exp Clin Transplant. 2008 Mar;6(1):14-24. Exp Clin Transplant. 2008. PMID: 18405240
-
[Adult-to-adult living donor liver transplantation using right lobe graft: report of 24 cases].Zhonghua Yi Xue Za Zhi. 2006 Feb 14;86(6):411-5. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16677554 Chinese.
-
Living donor liver transplantation for hepatocellular carcinoma: the Japanese experience.Oncology. 2011;81 Suppl 1:111-5. doi: 10.1159/000333270. Epub 2011 Dec 22. Oncology. 2011. PMID: 22212944 Review.
-
Living donor liver transplantation: present status and recent advances.Br Med Bull. 2006 Feb 10;75-76:15-28. doi: 10.1093/bmb/ldh058. Print 2005. Br Med Bull. 2006. PMID: 16474043 Review.
Cited by
-
Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.Surg Today. 2017 Apr;47(4):403-415. doi: 10.1007/s00595-016-1337-1. Epub 2016 Apr 29. Surg Today. 2017. PMID: 27130463 Review.
-
Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine.Organogenesis. 2014 Apr-Jun;10(2):241-9. doi: 10.4161/org.29245. Epub 2014 May 16. Organogenesis. 2014. PMID: 24836922 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical